Internet-derived data and AI enhance seasonal allergy predictions, revealing patterns and regional variations crucial for public health management in the U.S.
Heidelberg Pharma Reports on First Half-Year 2024 and the Course of Business – Biotech Investments
EQS-News: Heidelberg Pharma AG / Key word(s): Half Year Report Heidelberg Pharma Reports on First Half-Year 2024 and the Course of Business 11.07.2024 / 07:05